Bio Green Med Solution Form 4: 110,749 shares sold at $1.834

Rhea-AI Filing Summary

Bio Green Med Solution (BGMS) insider transaction: A reporting person filed a Form 4 showing a sale of common stock. On 10/29/2025, the insider sold 110,749 shares of BGMS common stock at a price of $1.834 per share. Following the transaction, the filer beneficially owned 140,760 shares, held as Direct (D) ownership.

The filing indicates it was submitted by one reporting person and relates to non-derivative securities only; no derivative transactions were reported. The issuer is Bio Green Med Solution, Inc. (BGMS).

Insider Trade Summary

Net Seller: 110,749 shares ($203,114)

Net Sell 1 txn

Insider Yap Kim Choy

Role 10% Owner

Sold 110,749 shs ($203K)

Type	Security	Shares	Price	Value
Sale	Common Stock	110,749	$1.834	$203K

Holdings After Transaction: Common Stock — 140,760 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yap Kim Choy

(Last) (First) (Middle)

18-25-3A THE WHARF RESIDENCE

TAMAN PUCHONG PRIMA

(Street)

PUCHONG N8 47200

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bio Green Med Solution, Inc. [ BGMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/29/2025		S		110,749	D	$1.834	140,760	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Yap Kim Choy	10/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BGMS report in this Form 4 filing?

An insider reported selling 110,749 shares of BGMS common stock on 10/29/2025 at $1.834 per share.

How many BGMS shares does the insider own after the sale?

The filer reported 140,760 shares beneficially owned following the transaction, held as Direct (D) ownership.

What was the transaction code on the Form 4?

The transaction code was S, which denotes an open market or private sale of non-derivative securities.

Were any derivative securities reported in this filing?

No. The filing lists no acquisitions or dispositions of derivative securities.

Who is the issuer and ticker symbol?

The issuer is Bio Green Med Solution, Inc. with ticker BGMS.

Was this filing made by a single reporting person?

Yes. It was Form filed by One Reporting Person.

What was the ownership form reported?

Ownership was reported as Direct (D).